Imugene's stock has surged this morning, on promising Phase 1b results for its azer-cel allogeneic CAR T-cell therapy. ...
Vous n'êtes pas connecté
Tryptamine's Phase 2a trial shows lessened pain, as well as improved sleep, and quality of life for fibromyalgia patients. ...
Imugene's stock has surged this morning, on promising Phase 1b results for its azer-cel allogeneic CAR T-cell therapy. ...
Imugene's stock has surged this morning, on promising Phase 1b results for its azer-cel allogeneic CAR T-cell therapy. ...
High-dose psilocybin is showing promise as a groundbreaking treatment for depression. Learn how it works, its benefits, and why it could revolutionize...
TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame...
A new MS drug Copaxone shows promise in reducing heart attack risk, offering potential benefits beyond multiple sclerosis for heart health and...
Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of...
In the two years since the U.S. Supreme Court started allowing states — what has become almost half of the country — to ban all or most abortions,...
A new study links energy drink consumption to poor sleep quality and insomnia among college students, highlighting the importance of informed choices...
Health experts said the medicine could give children more time without their brain tumour growing and improve quality of life.
Health experts said the medicine could give children more time without their brain tumour growing and improve quality of life.